Developing unique drug candidates aiming to reduce harmful inflammation and increase blood flow in the body’s microvasculature.

Health Care

Pharmaceutical

Gesynta Pharma

Gesynta Pharma's headquarters in Stockholm, Sweden

Patric Stenberg

Eva Johnsson

Sven Sievers

Göran Tornling

Michaela Gertz

Roger Franklin

Gunnar Olsson

William Gunnarsson

Jonas Brambeck

The Leadership Team at Gesynta Pharma drives the strategic direction and operational excellence of the company. Comprising key executives such as the CEO, Chief Financial Officer, Chief Medical Officer, VP of Project Management, and VP of Clinical R&D, this team ensures the successful development of innovative drug candidates to combat harmful inflammation and improve microvascular blood flow. They oversee financial management, clinical research, project execution, and overall corporate governance to achieve the company's mission.

Leadership Team

The Project Management and Clinical R&D team at Gesynta Pharma coordinates and oversees the development of innovative drug candidates. They manage clinical trials, spearhead research efforts in pharmacology and pre-clinical stages, and ensure projects progress efficiently from inception through regulatory approval, aiming to mitigate harmful inflammation and enhance microvascular blood flow.

��

Gesynta Pharma

Org chart

Board & advisors

Teams

Leadership Team

Project Management and Clinical R&D

Offices

��������

Gesynta Pharma

Org chart

Board & advisors

Teams

Leadership Team

Project Management and Clinical R&D

Offices

Related companies

��